Patent(s) and the Corresponding Patented Drug(s) |
Top |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US10202389 |
Title |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme |
Abstract |
Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein Y isand W, Z, XY, RY1, RY2 and RY3 are defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers. |
Applicant(s) |
Millennium Pharmaceuticals, Inc. |
Representative Drug(s) |
D0YE0V |
Drug Info
|
IC50 < 10nM |
Click to Show More |
[1] |
2
|
D0P3PT
|
Drug Info
|
IC50 < 10nM
|
[1] |
3
|
D0QQ3B
|
Drug Info
|
IC50 = 550 nM
|
[1] |
Patent ID |
US10202389 |
Title |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme |
Abstract |
Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein Y isand W, Z, XY, RY1, RY2 and RY3 are defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers. |
Applicant(s) |
Millennium Pharmaceuticals, Inc. |
Representative Drug(s) |
D0YE0V |
Drug Info
|
IC50 < 10nM |
Click to Show More |
[1] |
2
|
D0P3PT
|
Drug Info
|
IC50 < 10nM
|
[1] |
3
|
D0QQ3B
|
Drug Info
|
IC50 = 550 nM
|
[1] |
Patent ID |
US10202389 |
Title |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme |
Abstract |
Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein Y isand W, Z, XY, RY1, RY2 and RY3 are defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers. |
Applicant(s) |
Millennium Pharmaceuticals, Inc. |
Representative Drug(s) |
D0YE0V |
Drug Info
|
IC50 < 10nM |
Click to Show More |
[1] |
2
|
D0P3PT
|
Drug Info
|
IC50 < 10nM
|
[1] |
3
|
D0QQ3B
|
Drug Info
|
IC50 = 550 nM
|
[1] |